what's bio protocol?
Bio Protocol is a decentralized science (DeSci) platform that serves as a financial layer for the ecosystem, enabling the tokenization, governance, and commercialization of scientific research and innovations. It facilitates capital inflow into DeSci projects by providing tools for funding, staking, and community participation, bridging traditional science with blockchain technology to accelerate breakthroughs in areas like longevity, biotechnology, and AI-driven research. The protocol operates through mechanisms such as BioXP points, earned via staking BIO tokens or engaging in community activities like yapping (social contributions), which grant access to exclusive sales and rewards. It supports BioDAOs and BioAgents, allowing users to govern and fund specific scientific initiatives, while integrating with ecosystems like Ethereum and Base for seamless token interactions. Bio Protocol emphasizes transparency and incentives for genuine contributions, using features like veBIO locks for enhanced staking multipliers and IP tokenization for real-world R&D applications, fostering a collaborative environment where scientists, investors, and builders co-create the future of programmable biology.
Bio protocol's 2025 airdrop distributed $17,000 per eligible participant.
contract
ethereum
base
solana
Distributed airdrop in 2025 valued at $17,000 per eligible participant according to public farming results
releases a Shopify-like platform for research-backed health products
Season 2 launches with activation events completed at Binance Dubai and ADFW, currently participating in SolanaConf in UAE.
Three new tokenized research projects launch oversubscribed: $GALE (Alzheimer's inflammation), $RLV (regulated cannabinoid therapy), and $VITAFOXO (disc degeneration via gene splicing). $VITARNA demonstrates two clinically relevant delivery vectors for human application and lead researcher Dr. Michael Torres wins Best New Drug Developer at World ADC.
$PSY token holders within the Bio ecosystem vote to fund Next-Generation Empathogens research (MDMA alternatives).
BIO participates in DeSci Abu Dhabi event on December 10.
Bitstamp by Robinhood lists $BIO and $WLFI for trading.
BitMEX co-founder Arthur Hayes transfers 19.872M BIO ($1.2M) to Binance after unlocking 12.212M BIO ($730K) from vesting contract.
Arthur Hayes deposits 7.66M $BIO ($460K) to Binance, sitting on a 58% loss after withdrawing these tokens from Binance 3 months ago at $0.144.
Next ignition sale launches Monday featuring $RLV from newleaf_finance, a cannabis and hemp preroll project designed for targeted pain relief.
DogYearsDAO joins as a new project focused on longevity research and gene therapy for dogs with arthritis, with a token sale scheduled soon where dog owners earn tokens for participation and data becomes onchain IP.
BioXP Season 2 goes live with staking mechanism where users stake $BIO to earn bioxp, which is required to participate in token sales. @neurongale sale launches tomorrow with additional sales scheduled next week.
Bio Protocol Season 2 Ignition Sales features $DROPS (Skin Longevity Serum) and $GALE (Brain Inflammation Shield) as upcoming project launches.
AI research agents now autonomously pay for data using integrated x402 and Embedded Wallets, enabling instant USDC micropayments on Base for the previously announced bioagents feature.
BIO token displays 540.68% APR in funding rate arbitrage, appearing in top 10 opportunities list.
Bio Protocol powers AUBRAI, the first BioAgent to generate and own onchain IP, in collaboration with Molecule's Proof of Invention infrastructure.
Launchpad Season 2 announces new vesting structure of 20% at TGE and 80% over 30 days, integrations with Aerodrome Finance, Coinbase and BNB Chain, and x402 payments via bioagents feature with improved staking rewards.
Token experiences 12.67% price decline over 24 hours on October 21, ranking among crypto's biggest losers.
BioXP has 14-day expiration period with 2-3 launches monthly. User reports daily XP losses equal earnings, keeping XP flat, and threatens to unstake assets.
BIO lists on Upbit and DeSci coins soar, with BIO among today's hot coins.
Token lists on Upbit exchange today, with infrastructure changes to the protocol launchpad and BioXP rewards program scheduled this week.
South Korea's largest crypto exchange Upbit lists BIO trading pairs against KRW, BTC, and USDT.
BioXP yap farming bot swarms are active on eDMT-related accounts, resulting in the suspension of the @edmtcomms account.
Uses DeepProve zkML technology to verify AI outputs according to the zkML infrastructure provider.
Protocol has expanded to Solana via Wormhole NTT (Native Token Transfer) to enable multichain DeSci liquidity for biotech DAOs.
BioXP rewards are forfeited if users sell more than 50% of their holdings, creating a holding incentive for participants in the reward program.
Featured as the DeSci category leader in aixbt_agent terminal's list of 8 key crypto narratives.
Token has experienced an 81.4% FDV drop since its Token Generation Event, ranking as the third-worst performing protocol of the year among major launches.
Multiple ignition sales launch today including D1ckGPT (first APAC native team partnership, 500k FDV, 24h sale followed by TGE) with additional launches scheduled; BioXP expires this week with current technical issues being addressed.
Discussion with prominent crypto figure CryptoHayes (Arthur Hayes) took place regarding DeSci challenges, with an announcement or event scheduled within 12 hours.
Institutional liquid funds show positive sentiment toward the project after recent conversations, highlighting strong spot volume and community engagement, with volatility anticipated.
Smart Money increased BIO positions by 0.2% in the past 24 hours, indicating institutional accumulation activity.
Paul Kohls is currently presenting live at a DeSci event, discussing how he's building BioProtocol and Molecule with long-term sustainability in mind.
DeSci Singapore event featuring BIO is scheduled for Tuesday, September 30.
Yapping XP system pauses after September 24 for rework to filter bots and spam, while staking rewards continue with updated transparent formulas and higher multipliers for BIO stakers.
Two new bioDAO projects, PsyDAO and microbiomedao, complete coordinated token launches on the same day while collaborating on wellness research.
Staking BiomeAI tokens currently yields 10K BioXP per day, with another BioProtocol launch expected in approximately 20 days.
The team is developing a Research Agent using the Eliza framework for integration with Pearl, the AI Agent App Store, through the Olas SDK.
$eDMT, a first-of-its-kind commons IPT exploring brain DMT regulation, went live on the platform yesterday in collaboration with Molecule, Psy DAO, Noonautics and University of Florida.
AI agents serve as key catalysts for market performance, with AI trends up 3% weekly and approaching significant resistance levels.
BiomeAI launch achieves 5.2X oversubscription rate with 20 hours remaining in the pledging period.
YZi Labs (previously Binance Labs) invested in the project approximately 10 months ago, with the token currently trading at a $250m market cap and having reached an all-time high of over $1Bn in January 2025.
The first IPT launches on the platform with novel tokenomic design, and a second ignition agent sale completes in partnership with BiomeAI.
A new DeSci primitive called The Commons IPT will soon launch, representing a novel IP token model for open IP protection with initial funding directed toward DMT research.
BioProtocol secures $6.9 million funding round led by MaelstromFund.
The project reveals partnerships with AI startups SakanaAI Labs and FutureHouse, positioning itself competitively against closed Web2 AI companies.
Token surges 21% and leads top movers in the AI crypto sector alongside SNAI (+23%) and IRIS (+18%).
Project announces Chief of Staff hiring and hints at major development shift from "Raptor 1 to 2", indicating significant organizational scaling and potential protocol upgrade.
An Ignition Sale for $BIO and BioXP holders is scheduled to launch this week.
Ignition Sale launches next week for $BIO and BioXP holders, with latest BioXP rewards now live covering August 25-September 3 period.
BIO token gains 17.39% in 24 hours, ranking as third biggest crypto gainer on September 13th.
Staking XP rates increase to ~10k XP/day for ~$2200 in BIO assets, while user XP distribution shows most users earning 10k+ XP with yapping XP capped below 40k.
Today's XP delay may signal upcoming 'Yapping XP drop' reward distribution event.
Bio V2 and IP-Tokens are in development, while Aubrai has generated over 1,100 hypotheses with plans to scale experiments and assets.
Successful $BIO token launch delivers approximately 140x returns to presale participants with full token unlock.
$AUBRAI generates $180k in fees over 8 days on $20M volume with 980 novel hypotheses created, while upcoming terminal launch for academics and IPT funding launches are planned alongside the beginning of RMR2 study.
Staking XP rewards nearly double from ~2,300 to ~4,000 XP/day with new distribution model every 3-4 days, plus retroactive XP backdating to August 21st and new penalty system for selling over 50% of AUBRAI tokens.
BIO attracts $431K in smart money netflows, placing third in weekly rankings for institutional accumulation.
Trader reports concerning price action with suspicious daily wicks, suggesting potential market manipulation.
AUBRAI presale participants achieve 120x returns with 2x increase from liquid bottom.
Yapping XP feature launches this week ahead of next protocol release, with staking boost update pending.
New IP-NFT system enables cohort-based (10 people) hypothesis validation while preserving user privacy, with $BIOMES token rewards for contributing to collective knowledge validation.
Current staking metrics show 50% higher XP earning efficiency for AUBRAI assets (4.5 XP/$) compared to BIO tokens (3 XP/$).
Five new DeSci projects (MicrobiomeDAO, NootropicsDAO, DalyaDAO, MicroDAO, KidneyDAO) launch on platform, expanding ecosystem reach across medical research sectors with combined addressable market exceeding $296B.
New AI-powered BioAgent BiomeAI launches on platform with $BIOMES token incentive structure
New BioXP earning system launches for future token allocations through social engagement and $BIO staking.
Smart wallets are accumulating tokens according to Nansen data, with current circulating supply at 658k tokens.
First BioAgent digital twin launches on Base with $3.5M volume in 20 minutes, drawing 2000+ wallets in 14x oversubscribed sale.
Pledge event is 13.7x oversubscribed in $BIO with 2 hours remaining
Live bioagent launch reaches cap at 1.17M FDV, continues accepting BioXP point pledges with $BIO payment.
Token unlock of 20.96M tokens ($4.80M) scheduled for August 28, representing 0.63% of total supply and 1.05% of market cap.
Whale transfers 12M tokens ($3.79M) to Binance after receiving 4.8M ($1.53M) from vesting wallet, indicating potential selling pressure.
$4M earned in recent liquidity fees; expanding into DeFi with upcoming lending market integration.
First BioAgent Aubrai launches August 25th with VitaDAO and BioProtocol, targeting mouse lifespan extension through AI-driven research.
$BIO achieves 72.62% daily gain, leading crypto market gainers
Active hiring initiative launches for AI team with 69,000 $BIO referral bonus.
Perpetual futures trading launches on Kraken Pro with 20x leverage capability
Notable crypto trader Arthur Hayes purchases $1M worth of tokens.
First BioAgent Aubrai launches with 24-hour sale at $205k FDV, requiring BioXP and $BIO pledges.
New launchpad launches on Base network with BioXP-gated token sales and anti-dump mechanics requiring 2-week hold period to maintain BioXP earning capability.
Achieves 36.24% price increase while reaching #1 in combined social and market activity.
Demonstrates significant market momentum ranking #4 in combined social and market activity among major crypto assets.
Launchpad announces 12 new specialized healthcare DAOs covering men's health, disease research, longevity, and cognitive enhancement.
Current market cap stands at $200M, representing 20% of the total $1B DeSci market capitalization.
First BioAgent systems production deployment confirmed for second half of August.
Staking program achieves $8M TVL (5% of supply) on day one of Ethereum launch.
BioXP points system launches with retroactive rewards and IP-Token staking, tied to upcoming BioAgent sale.
New BioXP staking program launches with points system for future token launches.
Launches on Coinbase Assets, expanding market accessibility
Token price drops 70-80% amid increasing institutional flows and bot-dominated trading, marking shift away from community-focused distribution model.
Token listed on Coinbase, expanding market access and liquidity.
Added to Coinbase Assets roadmap, indicating potential future listing.
Team implements reward vesting strategy that enables token selling while yappers await zero-value delayed distributions.
New BioAgents launchpad product development confirmed, following successful models of Virtuals and CreatorBid.
Protocol implements encrypted vaults and scientist-trained AI agents for autonomous research, with trading volume directly funding new experiments.
Active recruitment underway for AI team expansion with focus on agentic systems, offering 1 ETH bounty for engineer and PM roles.
New DAOs launching in Guangzhou, Singapore, Seoul, and Kuala Lumpur to digitize TCM protocols and run crowdsourced trials.